Evidence map›Paper›PMID 1685446›Full record

ReviewEnvironmental health perspectives1991

Functional in vitro assays for the isolation of cell transformation effector and suppressor genes.

H Zarbl, C J Kho, M O Boylan, J Van Amsterdam, R C Sullivan, C D Hoemann, V L Afshani

Open access · diamondAbstract readReview
In one paragraph

Review in Environmental health perspectives, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

H ZarblDivision of Toxicology, Whitaker College of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139.
C J Kho
M O Boylan
J Van Amsterdam
R C Sullivan
C D Hoemann
V L Afshani
Massachusetts Institute of Technology · US

Funding

CLONING OF TRANSFORMATION EFFECTOR AND SUPPRESSOR GENESR01CA047571 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ZARBL, HELMUT · 1988 to 1996
–
TO INITIATE BIOCHEMICAL AND PHYSICAL STUDIES OF THE ARC PROTEINS07RR007047 · NCRR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WEDEEN, VAN J · 1985 to 1991
–
NCI NIH HHS 1-RO1-CA-47571NCRR NIH HHS 2-SO7-RR07047-22
6 · The paper itself

Abstract

Malignant transformation may be viewed as an imbalance between signals inducing cell growth and signals leading to growth inhibition, differentiation, or senescence. A basic understanding of how these counterbalancing forces interact to regulate normal cell growth is the prerequisite to comprehending the mechanisms of tumorigenesis. Identification and characterization of the gene products implicated in these regulatory pathways is the first step toward understanding the disease process. The studies outlined here provide the potential basis for isolating and molecularly characterizing transformation effector and suppressor genes, which must respectively function in the positive and negative regulation of normal cell growth. The general strategy used involves the isolation and molecular characterization of nontransformed variants (revertants) from populations of tumor cells. The selection of revertants is facilitated by the ability to separate normal from transformed cells by fluorescence-activated sorting. The basis for this separation is the differential retention of the fluorescent dye rhodamine 123 in the mitochondria of normal versus transformed cells. Using this approach, we have isolated revertants from a mutagenized population of v-fos-transformed Rat-1 fibroblasts. Characterization of these clones indicated that they had sustained causal mutations in transformation effector genes. The unmutated effector genes are being identified and molecularly cloned by isolating retransformed clones from revertant cell lines that have been transfected with DNA or cDNA from normal primary cells. The same selection protocol has also been used to isolate revertants from tumor cell lines that have been transfected with DNA or cDNA from primary cells. The putative tumor-suppressor genes present in these revertants are currently being analyzed.

Indexed as

Genes, Tumor SuppressorGenetic TechniquesOncogenesAnimalsCell FusionCell Line, TransformedCell SeparationCell Transformation, NeoplasticChromosome MappingCloning, MolecularFibroblastsFlow CytometryFluorescent DyesGenes, DominantGenes, RetinoblastomaMiceFluorescent DyesOncogene Proteins v-fosRhodamine 123Rhodamines

Identifiers

PMID1685446
PMCPMC1568065
OpenAlexW2044020281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.